PAR1 is selectively over expressed in high grade breast cancer patients: A cohort study

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Hernández, Norma A ^a   Correa, Elma ^a   Avila, Esther P ^a   Vela, Teresa A ^a   Pérez, Víctor M ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; PROTEINASE ACTIVATED RECEPTOR 1;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; PROGNOSIS; RISK FACTOR; BREAST TUMOR; COHORT ANALYSIS; FOLLOW UP; GENETIC SELECTION; GENETICS; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PAGET NIPPLE DISEASE; PATHOLOGY; SURVIVAL; TIME; TUMOR CELL LINE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, PAR-1; SELECTION, GENETIC; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 67650234471     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-47     Document Type: Article

References (31)

1. Bray F Ferlay J Pisan P Parkin DM Global CancerStatistics Cancer J Clin 2002, 55:74-108.
2. Registro Histopatológico de Neoplasias Malignas. Dirección General de Epidemiología, Secretaría de Salud Compendio de Cáncer 2002: Mortalidad y Morbilidad
3. Friedel G Pastorino U Ginsberg RJ Goldstraw P Johnston M Pass H International Registry of Lung metastases Results of lung metatarsectomy from breast cancer: Prognostic criteria on the basis of 467 cases of the International Registry of lung metastases Eur J Cardio-Thoracic Surg 2002, 22:335-344. 10.1016/S1010-7940(02)00331-7
4. Keyomarsi K Tucker SL Buchholz TA Callister M Ding YE Hortobagyi GN Bedrosian I Knickerbocker Ch Toyofuku W Lowe M Herliczek TW Bacus S Cyclin E and Survival in patients with breast cancer N Eng J Med 2002, 347:1566-1574. 10.1056/NEJMoa021153
5. Glondu M Liaudet-Coopman E Derocq D Platet N Rochefort H García M Down regulation of cathepsin-D in primary breast cancer has been associated with rapid development of clinical metastasis Oncogene 2002, 21:5127-5134. 10.1038/sj.onc.1205657 12140763
6. Siegel PM Shu W Cardiff RD Muller WJ Massagué J TGF beta signalling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc Natl Acad Sci USA 2003, 100:8430-8435. 166246 12808151 10.1073/pnas.0932636100
7. Bar-Shavit R Benezra M Sabbah V Bode W Vlodavsky I Thrombin as a multifunctional protein: Induction of cell adhesion and proliferation Am J Respir Cell Mol Biol 1992, 6(2):123-130. 1540375
8. Bangham J Moving PARts Nat Rev Cancer 2005, 5:247. 10.1038/nrc1601
9. Henrikson KP Salazar SL Fenton JW II Pentecost BT Role of thrombin receptor in breast cancer invasiveness Br J Cancer 1999, 79:401-406. 10.1038/sj.bjc.6690063 10027305
10. Arribas J Matrix metalloprotease and tumor invasion N Eng J Med 2005, 352:2020-2021. 10.1056/NEJMcibr055002
11. Coughlin SR Thrombin signaling and protease-activated receptor Nature 2000, 407:258-264. 10.1038/35025229 11001069
12. Nierodzik ML Chen K Takeshita K Huang LJ Feng XS DÁndrea MR Andrade-Gordon P Karpatkin S Protease-activated receptor 1 PAR1 is required and rate limiting for thrombin enhanced experimental pulmonary metastases Blood 1998, 92:3694-3700. 9808563
13. Kamath L Meydani A Foss F Kuliopulus A Signaling from Protease-activated receptors-1 inhibits migration and invasion of breast cancer cells Cancer Res 2001, 61:5933-5940. 11479236
14. Boire A Covic L Agarwal A Jacques S Sherifi S Kuliopulos A PAR1 is a matrix metalloprotease receptor that promotes invasion and tumorigenesis of breast cancer cells Cell 2005, 120:303-313. 10.1016/ j.cell.2004.12.018 15707890
15. Even-Ram SC Maoz M Pokroy E Reich R Katz BZ Gutwein P Altevogt P Bar-Shavit R Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin J Biol Chem 2001, 276:10952-62. 10.1074/jbc.M007027200 11278329
16. D'Ándrea MR Derian CK Santulli RJ Andrade-Gordon P Differential expression of protease activated receptors-1 and -2 in stromal fibroblasts of normal benign and malignant human tissues Am J Pathol 2001, 158:2031-2041. 1891970 11395381
17. Luttrell LM Daaka Y Lefkowitz RJ Regulation of tyrosine kinase cascades by G-protein coupled receptors Current Opinion Cell Biol 1999, 11:177-183. 10.1016/S0955-0674(99)80023-4 10209148
18. Knowlden JM Gee JM Robertson JF Ellis IO Nicholson RI A possible divergent role of oestrogen receptor α and β subtypes in clinical breast cancer Int J Cancer 2000, 89:209-212. 10.1002/ (SICI)1097-0215(20000320)89:2<209::AID-IJC17>3.0.CO;2-6 10754501
19. Elston W Ellis IO Pathological prognostic factors in breast cancer. The value of histologic grade in breast cancer: Experience from a large study with long-term follow-up Histopathol 1991, 19:403-410. 10.1111/ j.1365-2559.1991.tb00229.x
20. Skliris GP Carder PJ Lansdown MR Speirs V Immunohistochemical detection of ER beta in breast cancer: Towards more detailed receptor profiling? Br J Cancer 2001, 84:1095-1098. 10.1054/bjoc.2001.1721 11308260
21. Dowell JE Minna JD Chasing mutations in the epidermal growth factor in lung cancer N Engl J Med. 2005, 352(8):830-832. 10.1056/NEJMe058033 15728818
22. Ranson M Epidermal growth factor receptor tyrosine kinase inhibitors Br J Cancer 2004, 90:2250-2255. 15150574
23. Arora P Cuevas BD Russo A Johnson GL Trejo J Persistent transactivation of EGFR and ErB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion Oncogene 2008, 27:4434-4445. 10.1038/onc.2008.84 18372913
24. Fuqua SAW Schiff R Parra I Moore JT Mohsin SK Osborne CK Clark GM Allred C Estrogen receptor beta protein in human breast cancer: Correlation with clinical parameters Cancer Res 2003, 63:2434-2439. 12750263
25. Petit T Wilt M Velten M Millon R Rodier JF Borel C Mors R Haegelé P Eber M Ghnassia JP Comparative value of tumor grade, hormonal receptors, Ki-67, HER-2 and topoisomerase IIα status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy Eur J Cancer 2004, 40:205-211. 10.1016/ S0959-8049(03)00675-0 14728934
26. Atalay G Biganzoli F Renard F Paridaens R Cufer Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: A retrospective analysis of two prospective randomized metastatic breast cancer trials Eur J Cancer. 2005, 39(17):2439-2449. 10.1016/S0959-8049(03)00601-4
27. Roodman GD Mechanisms of bone metastases N Eng J Med 2004, 350:1655-1664. 10.1056/NEJMra030831
28. Covic L Gresser AL Talavera J Swift S Kuliopulos A Activation and inhibition of G-protein-coupled receptors by cell-penetrating membrane-tethered peptides Proc Natl Acad Sci USA 2002, 99:643-648. 117359 11805322 10.1073/pnas.022460899
29. Seeley S Covic L Jaqcques SL Sudmeier J Baleja JD Kuliopulos A Structural basis for thrombin activation of a protease-activated receptor: Inhibition of intramolecular liganding Chem Biol 2003, 10:1033-1041. 10.1016/j.chembiol.2003.10.014 14652070
30. Morris DR Yu D Ricks TK Gullapalli A Wolfe BL Trejo J Protease-activated receptor-2 is essenctial for factor VIIa and Xa-induced signaling, migration and invasion of breast cancer cells Cancer Res 2006, 66:307-14. 10.1158/0008-5472.CAN-05-1735 16397244
31. Arora P Ricks TK Trejo J Protease-activated receptor signalling endocytic sorting and disregulation in cancer J Cell Sci 2007, 120:921-928. 10.1242/jcs.03409 17344429